Compared to the healthy control subjects, plasma levels of NGAL were significantly higher among those with breast cancer (55.0 ng/ml (IQR: 25.8-124.7) versus 94.3 ng/ml (IQR: 39.3-207.6, p = 0.007). This evidence concerns the gene LCN2 and breast cancer.